Table 1. Correlation between Cryab expression and OS clinicopthological parameters.

		Result of immunostaining (No. of patients)
Parameter		Cryab-negative (n = 21/36)	Cryab-positive (n = 15/36)		p
Age (yrs)
	<19	13	8
	≥19	8	7	1.000
Gender
	Male	12	11
	Female	9	4	0.054
Site of primary tumor †
	Femur	14	8
	Tibia	3	3
	Humerus	3	2
	Pelvis	0	1
	Other	1	1	0.103
Histologic differentiation ††
	Osteoblastic	10	13
	Chondroblastic	2	2
	Fibroblastic	5	0
	Telangiectatic	3	0
	Other	1	0	0.049
Enneking stage ‡
	I	2	0
	IIA	6	1
	IIB	12	11
	III	1	3	0.001a
Response to chemotherapy *
	Good	15	7
	Poor	4	8
	NA	2	0	0.032
Metastasis
	Negative	14	4
	Positive	7	11	0.019

Note:

^†Femur vs. Tibia/ Humerus/Pelvis/Other;

^††Osteoblastic vs. Chondroblastic/ Fibroblastic/ Telangiectatic/Other;

^‡I/IIA vs. IIB/III;

^*good vs. poor/NA;

^aFisher's exact probability.